Lyophilised Oxalobacter formigenes (OxThera AB)

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameLyophilised Oxalobacter formigenes (OxThera AB)
Drug Alias NameOC 3OC5IxOC 3Lyophylised Oxalobacter formigenesOxalobacter +[9] 
ClassificationNatural product/Extract > Microbial extractBiologics
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsHyperoxaluria, Primary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[8] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOxthera Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxthera Inc
Active IndicationsN/A
Inactive IndicationsHyperoxaluria, Primary

Other Information

ATC CodeN/A
Related LinksN/A